You searched for "vascularisation"
Harry Moss Traquair: Edinburgh Ophthalmologist and Father Figure of Perimetry
It is a unique honour bestowed upon only a few clinicians, that their name becomes for evermore associated with the subject of their particular expertise and knowledge. Such an individual is undoubtedly Harry Moss Traquair, an Edinburgh-based ophthalmologist, who in...Assessing the effectiveness of undergraduate ophthalmic assessments in the UK: A literature review
During 2008–2009, 300,000 patients presented to hospital emergency departments in the UK with eye conditions. This rose by nearly 200,000 over the next decade. As the population ages, the prevalence of eye disease increases [1,2]. However, the stake ophthalmology holds...In conversation with John Forrester
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...
Lacrimal gland carcinoma
This is a major review of the management of lacrimal gland carcinoma, focusing mainly on adenoid cystic carcinoma. Relevant literature published in English since 1970 was included amounting to some 40 articles after filtering. Overall mortality for all lacrimal gland...A closer look at the new wave of glaucoma surgery – radical or old school?
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...Empowering primary care patients registered blind or partially sighted
With two million people in the UK living with visual impairment [1], being able to provide equitable and effective communication to this group of patients is essential in primary care. Yet, as highlighted by research conducted by Sight Loss Councils,...Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...‘Phaco-plus’ procedures at forefront of modern glaucoma management
Glaucoma and cataract increasingly present as a ‘two-in-one’ surgical opportunity. In the UK, new modelling suggests ~1 million adults aged ≥40 may currently have glaucoma, with a projected rise to ~1.6 million by 2060 as the population ages and demographics...
